Joann Evangelista | Head of Quality Assurance Affiliates - Product Development Quality
Genentech

Joann Evangelista, Head of Quality Assurance Affiliates - Product Development Quality, Genentech

Joann Evangelista is a distinguished pharmaceutical leader, renowned for her expertise in drug safety, quality assurance, and operational innovation. In her current role in Quality Assurance, she leads the development of country-level quality strategies to ensure confidence in the Quality Management System (QMS) across global affiliates. Leveraging Quality by Design (QbD) and Critical-to-Quality (CtQ) principles, Joann enables risk-based, evidence-driven assurance that strengthens compliance while accelerating business outcomes.

She has transformed traditional operations into AI-driven workflows, navigating complex regulatory environments while maintaining high-quality outcomes. Joann’s leadership in audits, inspection readiness, and compliance programs—paired with her ability to integrate advanced technologies—has driven substantial cost savings, improved inspection confidence, and increased operational efficiency. Her work positions quality not as a control function, but as a strategic enabler of speed, scalability, and sustainable growth.

Joann’s innovative approach has transformed high-volume, high-budget programs through business optimization and AI-driven interventions. Her expertise in evolving multifaceted operating models ensures continuous improvement, cost reduction, and enterprise-wide efficiency. By championing AI and automation across the value chain, she helps Genentech scale effectively as the pipeline grows in complexity and volume.

With a customer-centric, enterprise-wide mindset, Joann bridges quality, operations, and innovation—ensuring that governance frameworks not only meet regulatory expectations but also enable faster, smarter decision-making. Her leadership reflects a forward-looking vision for quality in a digital era, where assurance, innovation, and business performance are deeply interconnected.

Appearances:



Day 1: 14th October @ 11:45

Promoting Collaboration and Transparency Between Industry and Regulators to Support Meaningful GVP Compliance Oversight

last published: 10/Sep/26 22:25 GMT

back to speakers

Get Involved At patient Safety Congress Americas

 

CONNECT WITH US

 

 

To Sponsor

Kieron Carter
kieron.carter@terrapinn.com

+44 20 3481 8981

 

To Speak

Katherine O'Leary
katherine.oleary@terrapinn.com

 

Marketing & Press

Karolina Bzikot
karolina.bzikot@terrapinn.com